Anti-Radiation Medication created for the Star Army of Yamatai in YE 43 by the Yugumo Corporation.
This medication is the primary anti-radiation treatment for most Human and humanoid species.
The Star Army of Yamatai primarily utilizes Diethylenetriaminepentaacetic Acid sublingual tabs 1) as a chelation agent. It is generally the treatment of choice for exposure to plutonium, uranium and other actinides. It is most effective when applied quickly after exposure. Treatment generally continues daily for twelve days depending on exposure levels. Includes instructions for advanced application where dissolve tabs are combined to be diluted for IV applications.
Alternatively, this same medication can be administered also for exposure to most heavy-metals.
Diethylenetriaminepentaacetic Acid - Tabs | |
---|---|
Year of Creation | YE 43 |
Designer | Yugumo Corporation |
Nomenclature | Type 43 |
Alt. Nomenclature | N.A |
Manufacturer | Yugumo Corporation |
Fielded by | Yugumo Corporation, Star Army of Yamatai |
Availability | Mass Production |
1 Sealed Package | 30 sublingual tablets |
Case of 10,000 Packages | 300,000 pills |
Price | 30 KS/package, 195,000 KS/case unit |
Still available is the traditional treatment for exposure is Potassium Iodide. This treatment is not preferred because it only protects the thyroid from radioactive iodine. Suitable for specific and mass distribution during a radiological emergency.
Potassium Iodide Pills 130mg Tablet | |
---|---|
Year of Creation | YE 43 |
Designer | Yugumo Corporation |
Nomenclature | Type 43 |
Alt. Nomenclature | N.A |
Manufacturer | Yugumo Corporation |
Fielded by | Yugumo Corporation, Star Army of Yamatai |
Availability | Mass Production |
1 Sealed Package | 100 tablets |
Case of 10,000 Packages | 1,000,000 pills |
Price | 10 KS/package, 65,000 KS/case unit |
Nekovalkyrja and Minkan treatments for radiation exposure generally include the introduction of sterile hemosynthetic fluid. The unexposed femtomachinery in the new hemosynthetic fluid identifies cells containing radioactive isotopes as dysfunctional and eliminate them. Encapsulated waste products are then excreted through the skin and can be collected for disposal.
In the event of exposures on board Star Army of Yamatai vessels and facilities, the treatment can be introduced via aerosol by the Nodal Liquid Conduit System that was introduced in YE 42. Small group or individual treatments can be applied via Hemosynthetic Reconstruction Tube or in the event of field triage, it can be performed through traditional IV transfusion. In low-level exposures, the use of concentrated hemosynthetic pills can be used for treatment.
Concentrated Hemosynthetic Pills | |
---|---|
Year of Creation | YE 43 |
Designer | Ketsurui Zaibatsu |
Nomenclature | Type 43 |
Alt. Nomenclature | N.A |
Manufacturer | Ketsurui Zaibatsu |
Fielded by | Ketsurui Zaibatsu , Star Army of Yamatai |
Availability | Mass Production |
1 Sealed Package | 30 capsules |
Case of 10,000 Packages | 300,000 capsules |
Price | 30 KS/package, 195,000 KS/case unit |
Drugs, Medicines, and Pharmaceuticals | |
---|---|
Drug Name(s) | Star Army Medication Anti-Radiation |
Route of Administration | oral, sublingual (under the tongue) |
Drug Class | Antiradiation, Chelation agent |
Products & Items Database | |
---|---|
Product Categories | drugs, medical |
Product Name | Star Army Medication Anti-Radiation |
Nomenclature | Type 43 |
Manufacturer | Yugumo Corporation |
Year Released | YE 43 |
Price (KS) | 30.00 KS |